Literature DB >> 23478547

Blood transfusion requirement during liver transplantation is an important risk factor for mortality.

Abbas Rana1, Henrik Petrowsky, Johnny C Hong, Vatche G Agopian, Fady M Kaldas, Douglas Farmer, Hasan Yersiz, Jonathan R Hiatt, Ronald W Busuttil.   

Abstract

BACKGROUND: Blood loss during liver transplantation is not incorporated into the dominant models for post-transplant survival. Our objective was to investigate blood transfusion requirement as a risk factor for mortality after liver transplantation, and to further analyze risk factors for intraoperative blood transfusion requirement and hepatectomy time. STUDY
DESIGN: We conducted a retrospective analysis of 233 consecutive liver transplant recipients over a span of 3 years by a single experienced surgeon. Mean follow-up was 2.5 years. Independent risk factors for patient survival after liver transplantation were identified using Cox proportion hazard regression. Independent risk factors for intraoperative blood transfusion requirement and hepatectomy time were identified using logistic regression.
RESULTS: Two factors were identified as significant predictors in multivariate analysis for survival after liver transplantation: hepatocellular carcinoma (hazard ratio [HR] 1.9, 95% CI 1.1 to 3.2) and intraoperative blood transfusion requirement per unit (HR 1.01, 95% CI 1.0 to 1.02). Threshold analysis revealed that intraoperative blood transfusion volume ≥28 units or 85(th) percentile (HR 2.5, 95% CI 1.3 to 4.7) was a significant risk factor for patient survival. Four covariates were identified as significant risk factors for intraoperative blood requirement: warm ischemia time (odds ratio [OR] 1.12, 95% CI 1.06 to 1.18), bilirubin (OR 1.04, 95% CI 1.02 to 1.08), previous surgery (OR 1.7, 95% CI 1.02 to 2.9), and hepatectomy time (OR 1.01, 95% CI 1.00 to 1.02). The only risk factor for prolonged hepatectomy time was previous major abdominal surgery (OR 4.0, 95% CI 1.7 to 9.5).
CONCLUSIONS: Intraoperative blood transfusion requirement is an important risk factor for mortality after liver transplantation. The strongest risk factors for intraoperative blood transfusion requirement are warm ischemia time and bilirubin levels. Intraoperative blood loss and its risk factors should be incorporated into models to predict survival after liver transplantation.
Copyright © 2013 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23478547     DOI: 10.1016/j.jamcollsurg.2012.12.047

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  38 in total

1.  Massive blood transfusion after the first cut in liver transplantation predicts renal outcome and survival.

Authors:  Benedikt Reichert; Alexander Kaltenborn; Thomas Becker; Mario Schiffer; Jürgen Klempnauer; Harald Schrem
Journal:  Langenbecks Arch Surg       Date:  2014-03-30       Impact factor: 3.445

2.  Transfusion practice and knowledge in Mozambique.

Authors:  Emily Hartford; Olegario Muanantatha; Valigy Ismael Valigy; Sara Salimo; Alyssa Ziman; Daniel A DeUgarte
Journal:  Transfusion       Date:  2015-02-04       Impact factor: 3.157

3.  Preoperative thrombelastography maximum amplitude predicts massive transfusion in liver transplantation.

Authors:  Peter J Lawson; Hunter B Moore; Ernest E Moore; Gregory R Stettler; Thomas J Pshak; Igal Kam; Christopher C Silliman; Trevor L Nydam
Journal:  J Surg Res       Date:  2017-07-27       Impact factor: 2.192

4.  Pre-operative predictors of red blood cell transfusion in liver transplantation.

Authors:  Diogo Sobreira Fernandes; Cátia C Pereira Real; Paula A Sá Couto Romão; Filinto B Marcos Correia De Barros; Isabel M Marques Aragão; Luis F Guimarães Fonseca; José M Gonçalves Aguiar; Teresa M Costa Branco; Zélia M Fernandes Moreira; Simão M Barros Esteves
Journal:  Blood Transfus       Date:  2016-02-22       Impact factor: 3.443

Review 5.  Massive haemorrhage in liver transplantation: Consequences, prediction and management.

Authors:  Stuart Cleland; Carlos Corredor; Jia Jia Ye; Coimbatore Srinivas; Stuart A McCluskey
Journal:  World J Transplant       Date:  2016-06-24

6.  TETIS study: evaluation of new topical hemostatic agent TT-173 in tooth extraction.

Authors:  José López-López; Enric Jané-Salas; Amparo Santamaría; Beatriz González-Navarro; Carlos Arranz-Obispo; Ramón López; Ignasi Miquel; Belén Arias; Pilar Sánchez; Esther Rincón; Juan R Rodríguez; Santiago Rojas; Jesus Murat
Journal:  Clin Oral Investig       Date:  2015-09-15       Impact factor: 3.573

7.  A clinical coagulopathy score concurrent with viscoelastic testing defines opportunities to improve hemostatic resuscitation and enhance blood product utilization during liver transplantation.

Authors:  Alexander C Schulick; Hunter B Moore; Carson B Walker; Hillary Yaffe; James J Pomposelli; Fareed Azam; Michael Wachs; Thomas Bak; Peter Kennealey; Kendra Conzen; Megan Adams; Thomas Pshak; Rashikh Choudhury; Michael P Chapman; Elizabeth A Pomfret; Trevor L Nydam
Journal:  Am J Surg       Date:  2020-09-01       Impact factor: 2.565

8.  Transfusion management and immunohematologic complications in liver transplantation: experience of a single institution.

Authors:  Pilar Solves; Nelly Carpio; Federico Moscardo; Aima Lancharro; Isabel Cano; Angel Moya; Rafael López-Andujar; Miguel Ángel Sanz
Journal:  Transfus Med Hemother       Date:  2014-12-22       Impact factor: 3.747

9.  Bleeding and thrombotic complications of pediatric liver transplant.

Authors:  Alexandra J Borst; Debra L Sudan; Laura A Wang; Michael J Neuss; Jennifer A Rothman; Thomas L Ortel
Journal:  Pediatr Blood Cancer       Date:  2018-01-19       Impact factor: 3.167

Review 10.  Transfusion and coagulation management in liver transplantation.

Authors:  Ben Clevenger; Susan V Mallett
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.